Safety and efficacy of atezolizumab in the treatment of cancers: a systematic review and pooled-analysis
Yan Tie,1,2 Hui Yang,1 Rui Zhao,3 Heng Zheng,4 Daoke Yang,5 Jingyi Zhao,5 Ming Liu1,2 1Cancer Center, West China Hospital, Sichuan University, Chengdu, China; 2State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Chi...
Main Authors: | Tie Y, Yang H, Zhao R, Zheng H, Yang D, Zhao J, Liu M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/safety-and-efficacy-of-atezolizumab-in-the-treatment-of-cancers-a-syst-peer-reviewed-article-DDDT |
Similar Items
-
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
by: Zanuso V, et al.
Published: (2023-10-01) -
Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis
by: Xiaoqiang Gao, et al.
Published: (2023-07-01) -
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
by: Arndt Vogel, et al.
Published: (2021-05-01) -
Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety
by: K. Sharmni Vishnu, et al.
Published: (2022-11-01) -
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
by: Zhao C, et al.
Published: (2023-07-01)